EDGAR Filing Documents for 0001213900-24-031734

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001213900-24-031734

Filing Date

2024-04-10

Accepted

2024-04-10 08:00:51

Documents

166

Period of Report

2023-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	ea0201981-20f_altamirather.htm iXBRL	20-F	2793233
2	DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT	ea020198101ex2-13_altamira.htm	EX-2.13	121559
3	LIST OF SUBSIDIARIES	ea020198101ex8-1_altamira.htm	EX-8.1	3034
4	CERTIFICATION	ea020198101ex12-1_altamira.htm	EX-12.1	8941
5	CERTIFICATION	ea020198101ex12-2_altamira.htm	EX-12.2	8731
6	CERTIFICATION	ea020198101ex13-1_altamira.htm	EX-13.1	3889
7	CERTIFICATION	ea020198101ex13-2_altamira.htm	EX-13.2	3679
8	CONSENT OF DELOITTE AG	ea020198101ex15-1_altamira.htm	EX-15.1	2680
9	CONSENT OF BDO AG	ea020198101ex15-2_altamira.htm	EX-15.2	3964
10	COMPENSATION RECOVERY POLICY	ea020198101ex97-1_altamira.htm	EX-97.1	24931
11	GRAPHIC	ex15-1_001.jpg	GRAPHIC	7733
	Complete submission text file	0001213900-24-031734.txt		14275728

Data Files

Seq	Description	Document	Type	Size
12	XBRL SCHEMA FILE	cyto-20231231.xsd	EX-101.SCH	201554
13	XBRL CALCULATION FILE	cyto-20231231_cal.xml	EX-101.CAL	63902
14	XBRL DEFINITION FILE	cyto-20231231_def.xml	EX-101.DEF	569629
15	XBRL LABEL FILE	cyto-20231231_lab.xml	EX-101.LAB	1134652
16	XBRL PRESENTATION FILE	cyto-20231231_pre.xml	EX-101.PRE	595883
170	EXTRACTED XBRL INSTANCE DOCUMENT	ea0201981-20f_altamirather_htm.xml	XML	2574585

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000

Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94

Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)